Prof. Maysoon Al-Haideri| Drug Discovery |Best Researcher Award

Prof. Maysoon Al-Haideri|Drug Discovery|Best Researcher Award

Prof. Maysoon Al-Haideri at University oh Kurdistan Hewlêr,Iraq

PROFILE  

scopus 

 

Early Academic Pursuits 🎓

Dr. Al-Haideri began her educational journey at Baghdad University, where she completed her B.Sc. in Pharmacy in 1973. She demonstrated early promise and a strong interest in clinical analysis, leading her to pursue an Advanced Diploma in Clinical Analysis from Baghdad University between 1977 and 1979. Her academic curiosity and pursuit of excellence took her to the United States, where she attended Columbia University in the City of New York, earning a Master of Arts (M.A.) in 1983, followed by an M.Phil. in Pathology in 1985. Her dedication and passion culminated in a Ph.D. in Pathology from Columbia University in 1987, marking the beginning of an illustrious career in clinical research and academia.

Professional Endeavors 🩺

Dr. Al-Haideri’s professional career began in Iraq, where she gained practical experience and took on leadership roles in several medical institutions. She completed a traineeship in Clinical Hematology, Clinical Biochemistry, Medical Microbiology, Parasitology, and Infectious Diseases at the Ministry of Health in Baghdad from 1974 to 1975. Following this, she served as the Director of the Clinical Laboratory at Abo-Alkhaseab Hospital in Basrah (1975-1976) and Chief of the Clinical Biochemistry and Hematology Divisions at Al-Khadmia Teaching Hospital in Baghdad (1976-1981). During this time, she was also responsible for student supervision and training, highlighting her commitment to fostering the next generation of healthcare professionals.

From 1981 to 1982, Dr. Al-Haideri took on a national role as the Director of Quality Control and Standardization for all public clinical laboratories in Iraq, ensuring the consistent application of best practices in clinical analysis. Her leadership and expertise were further recognized when she undertook a traineeship in infertility at the Ministry of Health in Baghdad in 1982, signaling her growing influence in medical diagnostics and reproductive health.

In the United States, Dr. Al-Haideri continued her impressive trajectory, completing a postdoctoral fellowship at North Shore University Hospital, Manhasset, New York (1987-1988), followed by research positions at Long Island Jewish Medical Center (1988-1990) and Albert Einstein College of Medicine, Bronx, New York (1989-1991). During this time, she held the title of Instructor of Immunology, Rheumatology, and Allergy. Dr. Al-Haideri’s academic and research career reached new heights when she joined Columbia University’s College of Physicians and Surgeons, where she worked as an NIH Postdoctoral Research Trainee (1991-1994), eventually becoming an Associate Research Scientist and Assistant Professor (1994-2004).

Contributions and Research Focus 🔬

Dr. Al-Haideri’s research has primarily focused on clinical pathology, immunology, rheumatology, and allergy. Her work has been instrumental in enhancing the understanding of immunological responses in various pathological conditions. She has been actively involved in numerous research projects, often collaborating with leading medical institutions in both the U.S. and Iraq.

Her role as Director of Quality Control and Standardization in Iraq’s Ministry of Health laid the groundwork for the development of national policies aimed at ensuring the accuracy and reliability of clinical laboratory diagnostics across the country. In the U.S., her work at prestigious institutions like Columbia University and Albert Einstein College of Medicine helped advance the field of immunology, particularly in relation to autoimmune diseases.

Accolades and Recognition 🏆

Dr. Al-Haideri’s work has been widely recognized through various awards and honors. She received NIH Grant Awards from 1991 to 1994, which supported her groundbreaking research in immunology and pathology. Her academic excellence was also acknowledged at Columbia University, where she was awarded Graduate Research Assistantships.

Her commitment to medical education and healthcare development in Iraq earned her numerous accolades, including being named Employee of the Year at Hawler Medical University in Erbil, Kurdistan in 2012. Additionally, she received letters of appreciation from the Minister of Higher Education and Scientific Research in the Kurdistan region, as well as from the President of Hawler Medical University and several deans of colleges at the university for her contributions to education and healthcare.

Impact and Influence 🌍

Dr. Al-Haideri has had a profound impact on medical education and healthcare both in Iraq and abroad. As a leader in various institutions, she has played a critical role in shaping the medical education system in the Kurdistan Region of Iraq. Her tenure as Dean of the College of Health Sciences at Hawler Medical University (2014-2018) and Director of Quality Assurance (2010-2015) helped set new standards for academic excellence and institutional leadership in the region.

Her influence extends beyond academia. Dr. Al-Haideri has been an active member of numerous professional societies, including the American Society for Biochemistry and Molecular Biology and the American Heart Association, further cementing her status as a respected expert in her field. Her involvement in international organizations, such as the International Institute of Education in New York, reflects her commitment to global collaboration and knowledge exchange.

Legacy and Future Contributions 🔮

Dr. Maysoon Tahir Al-Haideri’s legacy is one of dedication to advancing medical knowledge, improving healthcare systems, and fostering academic excellence. Her work has had a lasting impact on the clinical and academic landscapes in Iraq, particularly in the Kurdistan region, where she has influenced generations of healthcare professionals through her leadership roles at Hawler Medical University and Cihan University-Erbil.

As she continues her work as the Director of the Pharmacy Program at the University of Kurdistan Hewler, Dr. Al-Haideri remains committed to mentoring students and contributing to the development of the healthcare sector in the region. Her achievements serve as an inspiration to future generations of scientists, educators, and healthcare professionals, ensuring her legacy will endure for years to come.

🎓Publication 

Silymarin suppresses proliferation and PD-L1 expression in colorectal cancer cells and increases inflammatory CD8+ cells in tumor-bearing mice

  • Authors   :Al-Haideri, M.
  • Journal    :Clinics and Research in Hepatology and Gastroenterology
  • Year         :2024

Functional and financial analysis of an inclined step solar desalination using phase change nanomaterials

  • Authors   : Mahal, A., Al-Haideri, M., Alkhouri, A., Obaidullah, A.J., Duan, M.
  • Journal    :Water Science and Technology
  • Year         :2024

Tuning the optoelectronic properties of selenophene-diketopyrrolopyrrole-based non-fullerene acceptor to obtain efficient organic solar cells through end-capped modification

  • Authors   :Ijaz, R., Waqas, M., Mahal, A., Alatawi, N.S., Aloui, Z.
  • Journal    :Journal of Molecular Graphics and Modelling,
  • Year         :2024

Rational designing of phenothiazine dioxide based hole transporting materials for efficient perovskite solar cells

  • Authors   : Hanan, M., Umair, Mahal, A., Farooq, Z., Mahr, M.S.
  • Journal    : Solar Energy,
  • Year         :2024

Linking the increasing epidemiology of scrub typhus transmission in India and South Asia: are the varying environment and the reservoir animals the factors behind?

  • Authors   : Mohapatra, R.K., Al-Haideri, M., Mishra, S., Mohanty, A., Sah, R.
  • Journal    :Frontiers in Tropical Diseases,
  • Year         :2024

Dr. S.K. Geetha|Pharmaceutical Analysis|Best Researcher Award

Dr. S.K. Geetha|Pharmaceutical Analysis |Best Researcher Award

Dr. S.K. Geetha at Government Arts College, Nandanam,India

PROFILE  

scopu

 Google scholar

 

Early Academic Pursuits 🎓

Dr. S.K. Geetha’s journey in the field of physics began with her foundational studies in Chennai. She obtained her M.Sc. in Physics from Queen Mary’s College (QMC), Chennai, and further pursued her M.Phil. in Physics at Madras Christian College (MCC), Tambaram. These prestigious institutions set the stage for her illustrious academic career. Her thirst for knowledge and a passion for research led her to complete her Ph.D. in Physics at Anna University, Chennai. Specializing in advanced research areas, she began honing her expertise, ready to contribute meaningfully to the field of physics both as an educator and researcher.

Professional Endeavors 🏫

Dr. Geetha’s teaching career spans an impressive 28 years at the undergraduate (UG) level and 15 years at the postgraduate (PG) level. She is currently an Associate Professor in the PG & Research Department of Physics at the Government Arts College for Men (Autonomous), Nandanam, Chennai, affiliated with Madras University. Her tenure has been characterized by dedication to both her students and the academic community.

Her pedagogical expertise is vast and covers a wide range of subjects. At the PG level, she has taught courses such as Statistical Mechanics, Condensed Matter Physics, Electromagnetic Theory, and Material Science, to name a few. For UG students, she has imparted knowledge in subjects like Basic Electronics, Mechanics, Quantum Mechanics, and Acoustics, ensuring a comprehensive understanding of fundamental and advanced physics concepts. Her commitment to preparing students for competitive exams such as CSIR-NET and PG TRB exams demonstrates her dedication to student success.

Research Focus and Contributions 🔬

Dr. Geetha’s research interests are diverse, encompassing a broad spectrum of physics topics. She has an impressive 27 years of research experience, guiding students at the M.Phil. and Ph.D. levels. Since being awarded Ph.D. guideship in 2015, she has successfully mentored one student who has been awarded a doctorate, while four others are currently pursuing their Ph.D. under her supervision.

Her contributions to physics research are further demonstrated through her editorial board membership in the International Journal of Materials Science and Application (IJMSA). Dr. Geetha has published significant work, including a noteworthy presentation titled “A Comparative, Experimental, Theoretical Study (DFT/B3LYP) of Antidepressant Drug Beta – Methyl Imipramine,” which was presented at the National Conference on Functional Materials and Its Application Aspects (NCFMAA-2022).

In addition to her research, Dr. Geetha is the author of the Tamil Nadu State Board Science Book (Physics) for Class 9, making an essential contribution to education at the school level. Her involvement in entrance coaching for CSIR-NET and other competitive exams further underscores her commitment to physics education.

Accolades and Recognition 🏆

Dr. Geetha’s excellence in teaching and research has not gone unnoticed. She was the recipient of the Best Teacher Award for the Year 2005-2006 at Meenakshi College of Engineering, Chennai. Her dedication to her students has also been recognized with a Certificate of Appreciation for producing a remarkable 92% result at Rajiv Gandhi College of Engineering. Dr. Geetha’s hard work and dedication earned her the confidence of the management, who appointed her to the Administrative Committee of Rajiv Gandhi College of Engineering.

Her services to the academic community were further acknowledged when she received a Certificate of Honour for her contributions to her college in 1992-1993. More recently, she was entrusted with TRB Confidential Work in October 2021, which speaks to the trust placed in her by the educational authorities. Her contributions have been further recognized with a Certificate of Merit for her paper presentation at NCFMAA-2022.

Impact and Influence 🌍

Dr. Geetha’s influence extends beyond the classroom and research labs. As a teacher, she has shaped the academic lives of countless students, fostering critical thinking, scientific curiosity, and a passion for physics. Her contribution to competitive exam coaching has empowered students to pursue advanced studies and careers in physics, elevating their academic pursuits.

Her editorial work with the International Journal of Materials Science and Application (IJMSA) reflects her commitment to fostering a platform for the dissemination of cutting-edge research. Dr. Geetha’s research, particularly in the field of antidepressant drug studies, continues to contribute valuable insights to both the academic and scientific communities.

Legacy and Future Contributions 🌱

Dr. S.K. Geetha’s legacy is one of dedication, academic excellence, and a tireless pursuit of knowledge. Her contributions to the field of physics, both as a teacher and researcher, have left an indelible mark on her students and colleagues alike. As a guide to future generations of physicists, her impact will continue to ripple through the academic community.

Moving forward, Dr. Geetha is poised to continue her research and mentorship roles, guiding more students through the rigors of academic research in physics. Her work on physics education, particularly through textbook authorship and curriculum development, will continue to influence young minds and contribute to the academic success of students across Tamil Nadu.

Conclusion 🎉

Dr. S.K. Geetha’s academic journey, professional accomplishments, and unwavering dedication to the field of physics have positioned her as a leading figure in physics education and research. Her legacy is defined by her contributions to academia, her influence on her students, and her continuous pursuit of knowledge. Dr. Geetha’s career is a testament to the impact a dedicated educator and researcher can have on the academic and scientific community, and her future contributions will no doubt further this legacy.

🎓Publication 

Habit modification and improvement in properties of potassium hydrogen phthalate (KAP) crystals doped with metal ions

  • Authors   :SK Geetha, R Perumal, S Moorthy Babu, PM Anbarasan
  • Journal    :Crystal Research and Technology: Journal of Experimental and Industrial Crystallography
  • Year         :2006

Computational investigation, comparative approaches, molecular structural, vibrational spectral, non-covalent interaction (NCI), and electron excitations analysis of …

  • Authors   :S Sarala, SK Geetha, S Muthu, Ahmad Irfan
  • Journal    :Journal of Molecular Modeling
  • Year         :2021

Theoretical investigation on influence of protic and aprotic solvents effect and structural (Monomer, Dimer), Van-der Waals and Hirshfeld surface analysis for clonidine molecule

  • Authors   : S Sarala, SK Geetha, S Muthu, Ahmad Irfan
  • Journal    : Computational and Theoretical Chemistry
  • Year         :2021

Vibrational spectra and Wavefunction investigation for antidepressant drug of Amoxapine based on quantum computational studies

  •  Authors   : S Sarala, SK Geetha, S Muthu, Fazilath Basha Asif
  • Journal    :Chemical Data Collections
  • Year         :2021

Probing solvent effect and strong and weak interactions in 2-Nitrophenyl-hydrazine using independent gradient model and Hirshfeld from wave function calculation

  • Authors   : S Sarala, SK Geetha, S Muthu, Ahmad Irfan
  • Journal    :  Molecular Liquids
  • Year         :2021

Prof. Rasha Azzam|Drug Discovery and Development|Best Researcher Award

Prof. Rasha Azzam|Drug Discovery and Development |Best Researcher Award

Prof. Rasha Azzam at Helwan University,Egypt

PROFILE  

orcid

Early Academic Pursuits 🎓

Prof. Rasha A. Azzam’s academic journey began with her outstanding performance in chemistry at Helwan University, Egypt, where she graduated with a Bachelor of Science (B.Sc.) in Chemistry in 1993. Her excellence in academia was recognized early on, as she graduated with class honors and was placed on the Dean’s List. Driven by her passion for organic chemistry, she pursued a Master of Science (M.Sc.) degree in Organic Chemistry at Helwan University, completing it in 1996. Her academic curiosity and dedication led her to further her studies internationally, earning a prestigious Ph.D. in Organic Chemistry in 2003 from the Catholic University of Leuven in Belgium. Her diverse educational background laid the foundation for a career defined by groundbreaking research and academic excellence.

Professional Endeavors 🧑‍🔬

Prof. Azzam’s professional career spans over two decades of teaching, research, and leadership in various prestigious academic institutions across the globe. She is currently a Professor of Organic Chemistry at the Faculty of Science, Helwan University, where she has been contributing since 2021. Prior to this, she held the position of Associate Professor of Organic Chemistry at the same institution from 2016 to 2021, demonstrating her upward trajectory in academia.

Her teaching and research influence extended beyond Egypt. She has held positions as an Associate Professor at Taibah University in Saudi Arabia, Nigerian Turkish Nile University in Nigeria, and the American University in Nigeria, where she was a co-founder of the Petroleum Chemistry Program. Additionally, she has served as a Visiting Professor at Virginia Commonwealth University in 2024, further showcasing her international academic reach.

Contributions and Research Focus 🔬

Prof. Azzam’s research focuses on organic and medicinal chemistry, with a particular emphasis on green synthesis, nanomaterials, and antiviral agents. One of her key research interests is the development of new methods for synthesizing compounds with potential anticancer and antimicrobial properties. Her recent project, “Synthesis of new sulfa derivatives under ultrasonic irradiation as potential anticancer/antimicrobial agents,” funded by Helwan University in 2021, highlights her innovative approach to organic synthesis.

Prof. Azzam’s work also explores environmentally friendly technologies, as demonstrated by her research on “green technology based on nanoporous biodegradable polymeric membranes” for wastewater treatment, funded by the Academy of Scientific Research Technology (ASRT). She has also conducted pioneering work on nanomaterials and their applications in industrial processes, such as her research on thermoplastic elastomers based on petrochemicals and the development of anti-COVID-19 agents incorporated into nanofibrous mats.

Her research output is extensive, and she has presented several projects on global platforms, including her work on antiviral therapeutic agents and nanomaterials. Her research contributions are shaping the future of organic chemistry, particularly in the domains of green chemistry and medical applications.

Accolades and Recognition 🏆

Prof. Azzam’s excellence in research and community service has been recognized through numerous awards and honors. In 2023, she received the prestigious Prince Mohammed Bin Fahd Scientific Award for her contributions to scientific production that serves community development within the framework of sustainable development goals. In the same year, she was honored with Helwan University’s Outstanding Scientific Achievement Award in Basic and Applied Sciences.

She has also been recognized for her mentoring and supervision of students, receiving Best Master Thesis Awards for two of her master’s students, Rasha Essam (2020) and Heba Elboshi (2023). Her commitment to advancing research was further acknowledged when she received the Research Excellence Awards for her students, Rokia Ramadan (2019) and Rasha Essam (2020). Additionally, Prof. Azzam was awarded a Silver Medal from the Academy of Scientific Research Technology (ASRT) in 2018 for her outstanding contributions to science.

Her impact extends internationally, with her receiving the Outstanding Faculty Member Award from the American University in Nigeria in 2007, and a research scholarship from the Catholic University of Leuven in 2001.

Impact and Influence 🌍

Prof. Azzam’s influence is felt not only through her research but also through her active participation in the scientific community. She serves as a Review Editor for Organic Chemistry on the Editorial Board of Frontiers in Chemistry and as an editor for the Journal of Chemistry and The Scientific World Journal, both published by Hindawi. She is also a grant evaluator for the Fulbright Binational Scholarship Program, where she helps assess the next generation of academic leaders.

Her commitment to education and community service is reflected in her involvement in organizing training workshops for high school teachers and instructing lab sessions for the AUN Community School. Prof. Azzam is also a member of the Egyptian Society for Basic Sciences, where she contributes to the development of the scientific community in Egypt.

Legacy and Future Contributions 🌟

Prof. Rasha A. Azzam’s legacy is built on her unwavering dedication to advancing organic chemistry, fostering academic excellence, and mentoring the next generation of scientists. Her research has laid the groundwork for significant developments in green chemistry, nanomaterials, and medicinal chemistry. With her continued focus on innovative solutions for pressing global challenges, such as wastewater treatment and the development of antiviral agents, she is poised to make even more impactful contributions in the years to come.

🎓Publication 

In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives

  • Authors   :Toka I. Ismail; Nashwa El-Khazragy; Rasha A. Azzam
  • Journal    :RSC Advances
  • Year         :2024

Novel High-Performance Functionalized and Grafted Bio-Based Chitosan Adsorbents for the Efficient and Selective Removal of Toxic Heavy Metals from Contaminated Water

  • Authors   :Mohammad Monir; Rasha E. Elsayed; Rasha Azzam; Tarek M. Madkour
  • Journal    :Polymers
  • Year         :2024

Crystal structure of 4-(benzo[d]thiazol-2-yl)-1,2-dimethyl-1H-pyrazol-3(2H)-one

  • Authors   :Heba A. Elboshi; Rasha A. Azzam; Galal H. Elgemeie; Peter G. Jones
  • Journal    :Acta Crystallographica Section E Crystallographic Communications
  • Year         :2024

Synthesis of New Guanidine Benzothiazole Derivative and Its Application as Eco-Friendly Corrosion Inhibitor

  • Authors   : Abdel-karim, Amal M.; Azzam, Rasha A.; Shehata, Omnia S.; Adly, Mohamed A.; El-Shamy, Omnia A. A.; El-Mahdy, Gamal A.
  • Journal    :Chemistry
  • Year         :2023

Crystal structure of 2-{[5-(methylsulfanyl)-4-phenyl-4H-1,2,4-triazol-3-yl]methyl}benzo[d]thiazole

  • Authors   : Rasha A. Azzam; Galal H. Elgemeie; Heba A. Elboshi; Peter G. Jones
  • Journal    :Crystallographica Section E Crystallographic Communications
  • Year         :2023

Prof Dr. Ali Shayanfar|Pharmaceutical Chemistry |Best Researcher Award

Prof Dr. Ali Shayanfar|Pharmaceutical Chemistry |Best Researcher Award|

Prof Dr. Ali Shayanfar at abriz University of Medical Sciences, Iran

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Shayan Fara began his academic journey at the Faculty of Pharmacy, Tabriz University of Medical Sciences, where he earned his Pharm.D. from 2003 to 2009. During these formative years, he developed a strong foundation in pharmaceutical sciences, laying the groundwork for his future career. His passion for pharmaceutical chemistry drove him to pursue a Ph.D. in the same field at Tabriz University of Medical Sciences from 2009 to 2013. His doctoral research focused on the solid-state and solution chemistry of drugs, an area that would later become a central theme of his research.

Professional Endeavors and Career Growth 🏢

After completing his Ph.D., Dr. Fara joined the Faculty of Pharmacy at Tabriz University of Medical Sciences as an Assistant Professor of Pharmaceutical Chemistry in 2014. His dedication to teaching and research led to a steady rise in his academic career. By 2018, he had been promoted to Associate Professor, and in 2023, he reached the pinnacle of his academic career by becoming a full Professor of Pharmaceutical Chemistry.

Dr. Fara’s professional endeavors extend beyond teaching. He has held several key administrative positions, including serving as the Secretary and Research Secretary of the Student Research Committee at Tabriz University of Medical Sciences. His leadership skills and commitment to research were further recognized when he became the Head of the Student Research Committee from 2018 to 2020.

Contributions and Research Focus 🧪

Dr. Fara’s research interests are diverse and impactful, focusing on the solid-state and solution chemistry of drugs, pharmaceutical and biomedical analysis, and modeling in pharmaceutical sciences. He has made significant contributions to understanding the physical and chemical properties of drugs in both solid and solution states. His work in this area has implications for drug formulation, stability, and bioavailability, making it crucial for the development of more effective pharmaceutical products.

His expertise extends to various analytical techniques, including UV-Vis spectrophotometry, HPLC, spectrofluorimetry, FT-IR, DSC, and PXRD. He has also conducted extensive research in chemometrics, molecular modeling, QSAR and QSPR studies, solubility and dissolution rate determination techniques, and crystallization of drugs. His technical prowess in these areas has enabled him to contribute to the advancement of pharmaceutical sciences, both in theory and practice.

Accolades and Recognition 🏆

Throughout his career, Dr. Fara has received numerous accolades and recognition for his contributions to pharmaceutical sciences. His role as an editor in several prestigious journals, including being the Editor-in-Chief of the Pharmaceutical Sciences Journal since 2020, highlights his influence in the field. He has also served as an Associate Editor for the Pharmaceutical Sciences Journal from 2014 to 2020 and for the Directory of Open Access Journals (DOAJ) from 2017 to 2018.

His editorial roles, combined with his contributions to research, have earned him a place on the editorial boards of several high-impact journals, including Pharmaceutical Sciences and ImmunoAnalysis. His involvement with these journals not only showcases his expertise but also his commitment to advancing the quality and accessibility of scientific knowledge.

Impact and Influence 🌍

Dr. Fara’s impact on the field of pharmaceutical sciences is profound. His research has influenced the development of new analytical methods and drug formulations, contributing to the broader field of pharmaceutical chemistry. His work in modeling and chemometrics has provided valuable insights into the relationship between drug properties and their therapeutic efficacy.

In addition to his research contributions, Dr. Fara has been instrumental in mentoring the next generation of pharmaceutical scientists. His teaching experience spans various subjects, including Analytical Chemistry, Medicinal Chemistry, Instrumental Analysis, General Chemistry, Medical Information Systems, Research Methods, Endnote Software, and Ethics in Publication. His dedication to education ensures that his influence will extend far beyond his direct contributions to research.

Legacy and Future Contributions 🌟

As Dr. Fara continues his career as a Professor of Pharmaceutical Chemistry, his legacy is already being built through his research, teaching, and editorial work. His ongoing contributions to the field, particularly in the areas of drug analysis and modeling, will continue to shape the future of pharmaceutical sciences. His commitment to excellence in research and education, combined with his leadership in various academic and editorial roles, ensures that his impact will be felt for years to come.

🎓Publication 

  • Authors   :Sahel Vahdati, Ali Shayanfar, Jalal Hanaee, Fleming Martínez, William E Acree Jr, Abolghasem JouybanA et al...
  • Journal    :Industrial & Engineering Chemistry Research
  • Year         :2013
  • Authors   :Abolghasem Jouyban, Mohammad Amin Abolghasemi Fakhree, Ali Shayanfar
  • Journal    :Journal of Pharmacy & Pharmaceutical Sciences
  • Year         :2010

Deep eutectic solvents for pharmaceutical formulation and drug delivery applications

  • Authors   :Shahram Emami, Ali Shayanfar
  • Journal    :Pharmaceutical development and technology
  • Year         :2020
  • Authors   : Hemayat Shekaari, Mohammed Taghi Zafarani-Moattar, Ali Shayanfar, Masumeh Mokhtarpour
  • Journal    :Journal of Molecular Liquids
  • Year         :2018
  • Authors   :Ommoleila Molavi, Farzaneh Narimani, Farshid Asiaee, Simin Sharifi, Vahideh Tarhriz, Ali Shayanfar, Mohammadsaied Hejazi, Raymond Lai
  • Journal    : Pharmaceutical biology
  • Year         :2017

Assoc Prof Dr. Mohammed Saddik |Formulation Science |Best Researcher Award

Assoc Prof Dr. Mohammed Saddik|Formulation Science |Best Researcher Award|

Assoc Prof Dr. Mohammed Saddik atFaculty of Pharmacy, Sohag University, Egypt

PROFILE  

 

Orcid

Early Academic Pursuits 🎓

Mohammed Sherif Saddik Ibrahim began his academic journey with a strong foundation in pharmaceutical sciences. He earned his Bachelor of Pharmaceutical Sciences from the Faculty of Pharmacy, Assiut University, Egypt, on July 22, 2006. His dedication to the field was evident early on, as he quickly advanced to pursue postgraduate studies. By July 24, 2011, he had obtained his Master’s degree in Pharmaceutical Sciences, specializing in pharmaceutics. His master’s thesis, titled “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Phenytoin,” highlighted his interest in the clinical applications of pharmaceuticals. Not stopping there, Mohammed continued his academic pursuits, earning a Doctor of Pharmaceutical Sciences (Ph.D.) in Pharmaceutics from Assiut University on January 24, 2017. His doctoral research focused on the “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Methylene Blue for Photodynamic Therapy,” showcasing his commitment to innovative therapeutic solutions.

Professional Endeavors 🧑‍🏫

Dr. Mohammed Sherif Saddik Ibrahim’s professional career is marked by his continuous advancement in academia and clinical practice. He began as a Pharmacist at Al-Azhar University Hospital, Faculty of Medicine, Assiut University, where he worked from July 24, 2007, to October 11, 2014. This role allowed him to gain practical experience in the pharmaceutical field, which he later integrated into his teaching and research.

In 2014, Mohammed transitioned to an academic role at Sohag University, Egypt, where he served as an Assistant Lecturer of Pharmaceutics and Clinical Pharmacy until February 26, 2017. Following his Ph.D., he was promoted to Lecturer in the same department, a position he held until June 27, 2022. His excellence in teaching and research led to his appointment as an Associate Professor of Pharmaceutics and Clinical Pharmacy at Sohag University on June 29, 2022, where he continues to contribute to the field. Additionally, since September 13, 2022, Mohammed has been coordinating the Clinical Pharmacy Program at Sohag University, further cementing his role as a leader in pharmacy education.

Contributions and Research Focus 💡

Dr. Mohammed Sherif Saddik Ibrahim’s research is centered around the formulation and clinical evaluation of pharmaceutical dosage forms. His work has significant implications for enhancing the therapeutic efficacy of drugs and improving patient outcomes. One of his notable research contributions includes the development of topical pharmaceutical dosage forms for photodynamic therapy, specifically using methylene blue. This research is particularly important for its potential in treating various skin conditions and diseases through non-invasive methods.

Mohammed’s innovative approach is also evident in his work on drug delivery systems. He has supervised multiple postgraduate students, guiding them in research that explores novel drug formulations and delivery methods. His expertise in handling lab animals and conducting clinical studies further supports his research goals, particularly in designing dosage forms that are both effective and patient-friendly.

Accolades and Recognition 🏆

Throughout his career, Dr. Mohammed Sherif Saddik Ibrahim has received recognition for his contributions to pharmaceutical sciences. His work has led to several patents, including those for sulfasalazine-loaded zinc oxide nanoparticles for the treatment of ulcerative colitis (US11730759B1) and a polymeric clotrimazole biofilm for the treatment of otomycosis (US11844781B1). These patents reflect his innovative thinking and commitment to developing new therapeutic solutions.

His academic contributions have also been recognized through his participation in significant conferences. Notably, he presented at the NUB 2nd Conference of Scientific Research in Pharmacy Future Insight at the Faculty of Pharmacy, Nahda University, in March 2019, and the 1st Conference of Pharmaceutical Sciences at Badr University in Cairo, held online in November 2021. These platforms allowed him to share his research findings with the broader scientific community and gain insights into the latest developments in pharmaceutical sciences.

Impact and Influence 🌍

Dr. Mohammed Sherif Saddik Ibrahim’s impact on the field of pharmaceutics extends beyond his research. As an educator, he has taught a wide range of courses at Sohag University, including Pharmaceutics, Physical Pharmacy, Community Pharmacy, Controlled Drug Delivery, and Pharmaceutical Legislations & Regulatory Affairs. His teaching not only imparts knowledge but also inspires the next generation of pharmacists and researchers. Mohammed’s role as a coordinator of the Clinical Pharmacy Program at Sohag University further amplifies his influence, as he shapes the curriculum and ensures that students receive a comprehensive and up-to-date education.

His contributions to research have also had a tangible impact on patient care. The dosage forms and drug delivery systems he has developed have the potential to improve the treatment of various conditions, from skin diseases to chronic illnesses like ulcerative colitis. By focusing on patient-centered research, Mohammed’s work is helping to bridge the gap between laboratory research and clinical practice, ultimately benefiting patients in Egypt and beyond.

Legacy and Future Contributions 🚀

As a progressive professional with a strong research background, Dr. Mohammed Sherif Saddik Ibrahim is poised to continue making significant contributions to the field of pharmaceutical sciences. His commitment to education and research, particularly in the area of drug delivery systems, positions him as a leader in the field. Looking ahead, Mohammed aims to further explore the green synthesis of nanomaterials and their application in drug delivery. His goal is to develop innovative pharmaceutical dosage forms that are not only effective but also environmentally sustainable.

Mohammed’s vision for the future includes expanding his research to address emerging medical challenges, such as diabetes and leukemia. With two patents already in progress for treatments in these areas, he is actively working towards solutions that could have a profound impact on global health. His determination to identify innovative approaches and improve medical outcomes drives his research and teaching efforts.

Conclusion 🌟

Dr. Mohammed Sherif Saddik Ibrahim’s career is a testament to his dedication to advancing pharmaceutical sciences. From his early academic pursuits to his current role as an Associate Professor and researcher, he has consistently sought to improve drug delivery systems and therapeutic efficacy. His contributions to education, research, and patient care have left a lasting impact, and his future work promises to bring even more innovative solutions to the field. As he continues to explore new frontiers in pharmaceutics, Mohammed’s legacy as a visionary educator and researcher will undoubtedly grow.

🎓Publication 

Formulation and evaluation of azithromycin-loaded silver nanoparticles for the treatment of infected wounds.

  • Authors   :Saddik MS; Al-Hakkani MF; Abu-Dief AM; Mohamed MS; Al-Fattah IA; Mahmoud Makki; El-Mokhtar MA; Marwa A. Sabet; Amin MS; Ahmed HA et al...
  • Journal    :pharmaceutics
  • Year         :2024

Characterization and Bio-Evaluation of the Synergistic Effect of Simvastatin and Folic Acid as Wound Dressings on the Healing Process

  • Authors   : Mahmoud A. Hashem; Badriyah S. Alotaibi; Mahmoud M.A. Elsayed; Manal E. Alosaimi; Amal K. Hussein; Maram Abduljabbar; Kyung-Tae Lee; Hamdy Abdelkader; Mohamed A. El-Mokhtar ; Ahmed Hassan et al.
  • Journal    :Pharmaceutics
  • Year         :2023

Synthesis, Physicochemical Characterization using a Facile Validated HPLC Quantitation Analysis Method of 4-Chloro-phenylcarbamoyl-methyl Ciprofloxacin and Its Biological Investigations

  • Authors   :Mostafa F. Al-Hakkani; Nourhan Ahmed; Alaa A. Abbas; Mohammad H. A. Hassan; Hossameldin A. Aziz; Ali M. Elshamsy; Hazim O. Khalifa; Mohamed A. Abdelshakour; Mohammed S. Saddik; Mahmoud M. A. Elsayed et al.
  • Journal    :Molecular Sciences
  • Year         :2023

Development of Novel Nano-Sized Imine Complexes Using Coriandrum sativum Extract: Structural Elucidation, Non-Isothermal Kinetic Study, Theoretical Investigation and Pharmaceutical Applications

  • Authors   : Shimaa Hosny; Randa F. Abd El-Baki; Zeinab H. Abd El-Wahab; Gamal A. Gouda; Mohammed S. Saddik; Ateyatallah Aljuhani; Ahmed M. Abu-Dief.
  • Journal    :Molecular Sciences
  • Year         :2023

In vitro and in vivo synergistic wound healing and anti-methicillin-resistant Staphylococcus aureus (MRSA) evaluation of liquorice-decorated silver nanoparticles

  • Authors   :Hamdoon Mohammed; Mohammed A. Amin; Gamal Zayed; Yassar Hassan; Mohamed El-Mokhtar; Mohammed S. Saddik..
  • Journal    : Antibiotics
  • Year         :2023

Prof. Anca Oana Hermenean |Pharmacology |Best Innovation Award

Prof. Anca Oana Hermenean|Pharmacology |Best Innovation Award|

Prof. Anca Oana Hermenean at Vasile Goldis Western University of Arad, Romania

PROFILE  

scopus

Orcid

Early Academic Pursuits 📚

Prof. Dr. Anca Hermenean began her academic journey at Babes-Bolyai University of Cluj-Napoca, Romania, where she earned her Bachelor’s degree in Biology from 1989 to 1994. This foundational education set the stage for her extensive career in biochemistry and molecular biology. Her academic prowess continued to shine as she pursued a PhD in Biology from 1997 to 2003, focusing on electron microscopy, histopathology, and immunohistochemistry. This period of intense study was marked by rigorous research and a commitment to understanding the microscopic and molecular mechanisms underlying various biological processes.

Professional Endeavors 🏛️

Prof. Hermenean’s professional career is distinguished by her roles in academia and research management. Since 2010, she has served as a Professor at the Faculty of Medicine, Vasile Goldis Western University of Arad (VGWU), where she has made significant contributions to the fields of histology and cell biology. Her expertise in these areas is evidenced by her ongoing research and teaching responsibilities.

In 2016, Prof. Hermenean was appointed Director of the VGWU Doctoral Studies Council, a role in which she has overseen the management and strategic development of doctoral programs in Medicine and Biology. Her leadership extended further in 2017 when she joined the Faculty of Engineering in Foreign Languages at Politehnica University of Bucharest, contributing to the Master Program in Biomaterials for Tissue Engineering. She has taught various courses related to cell and tissue biology, tissue regeneration, and debilitating diseases of tissue.

In 2020, Prof. Hermenean became the Director of the Life Science Institute and Principal Investigator at the Institute of Life Sciences, VGWU. Here, she manages research projects and oversees activities in microscopy labs and the animal facility, reflecting her deep engagement in both research and administration.

Contributions and Research Focus 🔬

Prof. Hermenean’s research contributions are broad and impactful, focusing on several key areas:

  1. Histology and Histopathology: Her work in these fields explores the microscopic structure of tissues and the pathological changes associated with various diseases. This includes significant contributions to understanding how cellular and tissular alterations can affect health.
  2. Phytomedicine: Prof. Hermenean has researched the modulation of signal transduction pathways by phytochemicals, their molecular regulation of anti-inflammatory and anti-fibrotic responses, and their interactions with drugs and chemicals.
  3. Nanobiotechnology: She has been involved in the characterization of bio-interfaces and in vivo biocompatibility studies of nanomaterials. Her work includes assessing the interactions between nanomedicines and biological systems, as well as evaluating structural and ultrastructural toxicological effects.
  4. Regenerative Medicine: Prof. Hermenean’s research also covers tissue repair and regeneration pathways, focusing on molecular signals, growth factors, and the mechanisms of tissue regeneration.

Accolades and Recognition 🏆

Prof. Hermenean’s work has garnered significant recognition within the scientific community. She holds a habilitation in Biology, a postdoctoral qualification that allows her to supervise PhD candidates. Her research has led to numerous publications in peer-reviewed journals, with an H-index of 30 on Scopus and 34 on Google Scholar. Additionally, she has been awarded several patents for her innovations in pharmaceutical compositions and drug delivery systems, underscoring her contributions to practical and applied sciences.

Impact and Influence 🌍

Prof. Hermenean’s influence extends beyond her research and teaching. Her roles in managing research councils and institutes highlight her ability to shape research strategies and educational programs. Her contributions have had a tangible impact on the advancement of biomedical sciences, particularly in the fields of histology, nanobiotechnology, and regenerative medicine.

Her work on phytomedicine and nanobiotechnology is particularly notable for its potential applications in developing new therapeutic approaches and improving existing medical treatments. Her patents and research projects reflect her commitment to translating scientific discoveries into practical solutions.

Legacy and Future Contributions 🔮

Prof. Hermenean’s legacy is marked by her dedication to advancing scientific knowledge and training the next generation of researchers. Her leadership in establishing and managing research infrastructures, such as the animal facility and microscopy labs at VGWU, demonstrates her commitment to fostering a supportive environment for cutting-edge research.

Looking ahead, Prof. Hermenean is poised to continue making significant contributions to her fields of expertise. Her ongoing research and collaborations are expected to yield further advancements in phytomedicine, nanobiotechnology, and regenerative medicine. Her role as a mentor and educator will also play a crucial part in shaping future research and development in these areas.

🎓Publication 

Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver

  • Authors   :Balta, C., Herman, H., Ciceu, A., D’Amico, M., Hermenean, A..
  • Journal    :Biochemical Pharmacology
  • Year         :2024

Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice

  • Authors   :Wang, S., Yu, X., Cheng, L., Lu, Y., Wu, X..
  • Journal    :Cell Death and Disease
  • Year         :2024

Exploring In Vivo Pulmonary and Splenic Toxicity Profiles of Silicon Quantum Dots in Mice

  • Authors   :Cristian, R.-E., Balta, C., Herman, H., Dinischiotu, A., Stan, M.S..
  • Journal    :Materials.
  • Year         :2024

Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system

Colloidal and Biological Characterization of Dual Drug-Loaded Smart Micellar Systems

  • Authors   :Herman, H., Rata, D.M., Cadinoiu, A.N., Atanase, L.I., Hermenean, A..
  • Journal    :Polymers
  • Year         :2024

Dr.Long Pang |Oncology Pharmaceuticals| Best Researcher Award-1332

Dr.Long Pang|Oncology Pharmaceuticals |Best Researcher Award|

Dr.Long Pang at Xi’an Medical University, China

PROFILE  

scopus

Early Academic Pursuits 📚

Long Pang was born in Gansu, China, where he developed an early passion for science and innovation. His academic journey began with a focus on veterinary science, where he pursued a Master of Science (M.S.) degree at Northwest Agricultural and Forestry University in Yangling, Shaanxi, China. Completing his M.S. in July 2012, Pang demonstrated an exceptional commitment to his studies and research in veterinary science, laying the groundwork for his future endeavors in animal biotechnology. In August 2012, he advanced his academic career by enrolling in a Ph.D. program at the same university. During his Ph.D. studies, he specialized in Animal Biotechnology, a field that encompasses the use of biotechnological tools for the improvement of animal health and productivity. He completed his Ph.D. in July 2016, marking the beginning of a promising career in biomedical research.

Professional Endeavors 🏢

After earning his Ph.D., Long Pang joined Xi’an Medical University as an Associate Professor in the School of Basic Medical Science. His professional career is distinguished by his innovative research in the areas of microfluidics and single-cell analysis. At Xi’an Medical University, Pang quickly established himself as a leading researcher, focusing on the development of microfluidic chips and their applications in single-cell analysis and organ-on-a-chip technology. His work has been instrumental in advancing the understanding of cellular mechanics and tumor microenvironments, contributing significantly to the fields of biomedical engineering and cancer research.

Contributions and Research Focus 🔬

Long Pang’s research primarily revolves around microfluidics-based single-cell analysis and organ-on-a-chip technologies. His work has led to the development of innovative microfluidic devices that allow for the manipulation and analysis of single cells in a highly controlled environment. These devices have broad applications in cancer research, particularly in studying tumor microenvironments and the behavior of cancer stem cells. One of his significant contributions includes the development of a microfluidic chip for glioma stem cell sorting and single-cell-derived tumor sphere assays. This research has provided valuable insights into the formation of tumor spheres and the role of the tumor microenvironment in cancer progression.

Pang has also been involved in projects aimed at integrating microfluidic platforms with other technologies to enhance the precision and efficiency of single-cell analysis. His research has been supported by several prestigious grants, including those from the National Science Foundation of China and the Fundamental Research Foundation of Xi’an Medical University. Notably, he has led projects such as the study of heterotypic single-cell-derived tumor-sphere formation using an integrated microfluidics platform, which has garnered significant attention and funding.

Accolades and Recognition 🏆

Long Pang’s contributions to the field of biomedical research have been widely recognized. His work has resulted in over 21 publications in high-impact journals, including TRAC-Trends in Analytical Chemistry, Analytical Chemistry, and Sensors & Actuators B: Chemical. He has also authored a chapter in the Handbook of Single-Cell Technologies, published by Springer, highlighting his expertise in digital microfluidics for single-cell manipulation and analysis. In addition to his publications, Pang has been granted two Chinese patents related to his innovations in microfluidic technology, further establishing his reputation as a leading researcher in his field.

Pang’s achievements have also been acknowledged through various editorial appointments. He has served as a Youth Editorial Board Member of Glioma and the E-Journal of Translational Medicine, where he has contributed to the advancement of research dissemination and knowledge sharing in the scientific community. His contributions to the academic community extend beyond research, as he is an active member of several professional organizations, including the Shaanxi Pharmacology Association, the Chinese Society of Micro-Nano Technology (CSMNT), and the Chinese Chemistry Society (CCS).

Impact and Influence 🌍

The impact of Long Pang’s research extends beyond academia. His work on microfluidic devices has the potential to revolutionize the way single-cell analysis is conducted, offering new tools for researchers and clinicians in the diagnosis and treatment of diseases, particularly cancer. His contributions to the development of organ-on-a-chip technology are also significant, providing a platform for more accurate and efficient drug testing, which could lead to more effective treatments for various diseases.

Pang’s research has influenced a new generation of scientists and engineers, inspiring them to explore the possibilities of microfluidics and its applications in biomedical research. His collaborations with other leading researchers and institutions, both in China and internationally, have further expanded the reach of his work, fostering innovation and knowledge exchange in the global scientific community.

Legacy and Future Contributions 🚀

Long Pang’s legacy in the field of biomedical research is characterized by his innovative approach to solving complex problems in cell biology and medicine. His contributions to the development of microfluidic technology and single-cell analysis tools have set new standards in the field, paving the way for future research and innovation. As he continues his work at Xi’an Medical University, Pang remains committed to advancing the frontiers of biomedical engineering, with a focus on developing new technologies that can improve human health and well-being.

Looking to the future, Long Pang’s ongoing research projects, such as the construction of a 3D microenvironment for single-cell level tumor cells, promise to yield further breakthroughs in our understanding of cancer and other diseases. His work is likely to continue to influence the field for years to come, as he mentors the next generation of researchers and contributes to the global effort to improve healthcare through technological innovation.

🎓Publication 

Tumor microenvironment-derived exosomes-assisted single-cell-derived tumor-sphere formation and drug-resistance by a microfluidic system

Construction of multiple concentration gradients for single-cell level drug screening

Droplets microfluidics platform—A tool for single cell research

Microfluidics-Based Single-Cell Research for Intercellular Interaction

Digital Microfluidics for Single Cell Manipulation and Analysis

  • Authors   :Pang, L., Ding, J., Fan, S.-K.
  • Journal    :Handbook of Single-Cell Technologies
  • Year         :2021

Prof. Fatma YURT|pharmaceuticals | Best Researcher Award

Prof. Fatma YURT |pharmaceuticals|Best Researcher Award|

Prof. Fatma YURT atEge University,Turkey

PROFILE  

scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Fatma Yurt’s journey into the scientific world began at Ege University, one of Turkey’s leading institutions. She completed her undergraduate studies at the Faculty of Science in the Department of Chemistry between 1982 and 1987. Her passion for science and dedication to learning set the stage for her illustrious career in nuclear sciences. Following her bachelor’s degree, she pursued a doctorate at Ege University in the Institute of Nuclear Sciences, specializing in Nuclear Sciences. From 1991 to 1998, she immersed herself in the study of nuclear applications, gaining a deep understanding of the field’s complexities and potential. This period of intense academic focus and research laid a solid foundation for her future contributions to nuclear medicine, radiopharmacy, and related fields.

Professional Endeavors 💼

Prof. Dr. Fatma Yurt’s professional career is marked by her steady rise through the academic ranks at Ege University. She began her career as a Research Assistant in the Nuclear Applications Department of the Institute of Nuclear Sciences, where she served from 1994 to 1997. This role allowed her to engage in cutting-edge research and contribute to the development of nuclear sciences in Turkey.

In 1999, she was promoted to Assistant Professor, and later in the same year, she achieved the rank of Associate Professor. Her commitment to education and research was evident as she continued to mentor students and lead research projects in nuclear applications. By 2007, she had earned the title of Professor, solidifying her position as a leading expert in her field.

Prof. Dr. Yurt’s expertise is not limited to academia; she has also held significant administrative roles. Since 2016, she has served as the Director of the Institute of Nuclear Sciences at Ege University. In this capacity, she has been instrumental in shaping the direction of nuclear research and education in Turkey, overseeing various projects and initiatives that have expanded the institute’s influence both nationally and internationally.

Contributions and Research Focus 🔬

Prof. Dr. Fatma Yurt’s research spans several critical areas within nuclear sciences, with a particular emphasis on nuclear medicine, radiopharmacy, and pharmacology. Her work in these fields has been pivotal in advancing the understanding and application of nuclear techniques in medicine, particularly in diagnosing and treating various diseases.

Her research contributions include the development of novel radiopharmaceuticals, which are essential for diagnosing and treating conditions such as cancer. Prof. Dr. Yurt’s expertise in nuclear chemistry and physical chemistry has enabled her to explore the intricate processes involved in the synthesis and application of these compounds. She has also contributed significantly to the field of health sciences, particularly in the areas of internal medicine and pharmaceutical technology.

With a Scopus publication count of 123 and a Unisis publication count of 296, Prof. Dr. Yurt’s research output is impressive. Her work has been cited over 1,447 times on Scopus, reflecting the impact and relevance of her research. Her H-Index, a measure of both the productivity and citation impact of her publications, stands at 21 on Scopus, further underscoring her influence in the field.

Accolades and Recognition 🏆

Throughout her career, Prof. Dr. Fatma Yurt has received numerous accolades and recognition for her contributions to nuclear sciences and medicine. Her research has been widely acknowledged by her peers, and she has been invited to present her findings at various national and international conferences. Her role as the Director of the Institute of Nuclear Sciences is a testament to her leadership abilities and her dedication to advancing the field of nuclear applications.

Prof. Dr. Yurt’s work has not only advanced scientific understanding but has also had a tangible impact on healthcare. Her contributions to radiopharmacy have been particularly significant, with her research playing a crucial role in the development of new diagnostic and therapeutic methods. Her dedication to her field is further demonstrated by her ongoing involvement in academic mentorship, helping to train the next generation of scientists in nuclear sciences.

Impact and Influence 🌍

Prof. Dr. Yurt’s influence extends beyond her research and academic roles. As a leader in nuclear sciences, she has been instrumental in promoting the importance of nuclear applications in medicine and other fields. Her work has helped to bridge the gap between basic research and practical applications, ensuring that the benefits of nuclear science are realized in clinical settings.

Her leadership at the Institute of Nuclear Sciences has also been pivotal in shaping the research agenda in Turkey, encouraging interdisciplinary collaboration and fostering a culture of innovation. Under her guidance, the institute has strengthened its position as a center of excellence in nuclear research, attracting students and researchers from around the world.

Legacy and Future Contributions 🌟

Prof. Dr. Fatma Yurt’s legacy is one of dedication, innovation, and leadership. Her contributions to nuclear medicine, radiopharmacy, and related fields have had a lasting impact on both the scientific community and the broader healthcare sector. As she continues her work, her influence will undoubtedly grow, inspiring new research and leading to further advancements in nuclear applications.

🎓Publication 

An in vitro evaluation of Hypericum perforatum loaded-chitosan nanoparticle/agarose film as a Wound dressing

Unveiling combat strategies against Candida spp. biofilm structures: Demonstration of photodynamic inactivation with innovative phthalocyanine derivatives

Platinum (II) Schiff Base Complexes and their Effects on the Inhibition of Amyloid β1–42 Aggregation

In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer

  • Authors   :Tunçel, A., Maschauer, S., Prante, O., Yurt, F.
  • Journal    :Pharmaceuticals
  • Year         :2024

 

Ms. Faezeh Aghajannataj Ahangarkola|Drug Delivery Systems | Best Researcher Award

Ms. Faezeh Aghajannataj Ahangarkola |Drug Delivery Systems|Best Researcher Award|

Ms. Faezeh Aghajannataj Ahangarkola at Babol Noshirvani University of Technology,Iran

PROFILE  

Google scholar

 

Early Academic Pursuits 🎓

Faezeh Aghajannataj began her academic journey with a strong foundation in pure chemistry, earning a Bachelor of Science degree from the University of Mazandaran (UMZ) in Babolsar, Iran, in September 2018. Her undergraduate studies focused on the synthesis of pharmaceutical heterocyclics, particularly through multi-component reactions. Under the guidance of Dr. Robabeh Baharfar, Faezeh’s final project received a stellar grade of 4.0/4.0, demonstrating her early aptitude for research and her keen interest in the intersection of chemistry and pharmaceuticals.

Building on her success at UMZ, Faezeh pursued a Master of Science degree in Biotechnology at the Babol Noshirvani University of Technology (BNUT), Babol, Iran. Her graduate research centered on the development of enteric hard capsules for targeting the small intestine, utilizing innovative materials like Pullulan and Eudragit L-100. This research culminated in a thesis titled “Enteric Hard Capsules for Targeting Small Intestine by Pullulan and Eudragit L-100: Processing, Characterization, and In-vitro Drug Release,” which was awarded a perfect grade of 4.0/4.0 (19/20), reflecting the high quality and significance of her work under the mentorship of Dr. Ghasem Najafpour.

Professional Endeavors 🏢

Faezeh’s professional career is marked by a strong focus on research and development in the pharmaceutical and biotechnology industries. During her time at Iran Gelatin Capsule in Tehran, she played a pivotal role as a member of the R&D team from February 2022 to May 2023. Her work primarily involved researching and formulating pullulan capsules at an industrial scale, a task that required both technical expertise and innovative thinking. Additionally, she contributed to the formulation and evaluation of controlled release systems designed to produce enteric-coated capsules without synthetic materials or external coatings, a project that aligns with the growing demand for more natural and sustainable pharmaceutical solutions.

Faezeh also gained significant experience as a teaching assistant during her academic career. She assisted in courses such as Organic Chemistry Laboratory and Physical Chemistry Laboratory at UMZ, and Advanced Engineering Mathematics at BNUT, showcasing her ability to convey complex scientific concepts to students. Her teaching roles not only enriched her understanding of the subjects but also allowed her to contribute to the academic growth of her peers.

Contributions and Research Focus 🔬

Faezeh’s research interests lie at the crossroads of biotechnology, pharmaceutical sciences, and chemistry. Her master’s thesis on enteric hard capsules represents a significant contribution to the field of drug delivery systems, particularly in the development of targeted delivery mechanisms for the small intestine. This work, which involved detailed processing, characterization, and in-vitro drug release studies, has the potential to impact the way oral medications are formulated and administered, particularly in terms of improving drug efficacy and patient outcomes.

Her research has been recognized through the publication of her work in reputable scientific journals. One notable publication is “Towards a Novel Pullulan and Pullulan-Enteric Hard Capsules: Study of Drug Release and Crucial Capsule Features,” co-authored with Dr. Gh. Najafpour and R. Ramezani. This paper, accessible , highlights the innovative approach Faezeh has taken in her research, contributing valuable knowledge to the field of drug delivery systems.

Accolades and Recognition 🏆

Throughout her academic and professional career, Faezeh has consistently achieved high marks and recognition for her work. Her thesis was awarded a perfect grade, reflecting the high esteem in which her research is held. Additionally, her academic achievements during her bachelor’s and master’s studies are underscored by her strong GPA, which stands at 3.6/4.0 (16.95/20) for her master’s degree, and her consistently high grades in her coursework.

Her work has also been recognized within the academic community through her roles as a teaching assistant, where she earned the trust of her professors to guide and mentor students in complex scientific subjects.

Impact and Influence 🌍

Faezeh’s research on drug delivery systems, particularly her focus on enteric capsules, has the potential to significantly impact the pharmaceutical industry. By developing more effective and targeted drug delivery mechanisms, her work could lead to improved patient outcomes, particularly for those with conditions that require precise delivery of medication to the small intestine.

Her influence extends beyond her research, as her roles as a teaching assistant and R&D member have allowed her to mentor and collaborate with others in the field, spreading her knowledge and fostering innovation in both academic and industrial settings.

Legacy and Future Contributions 🌟

Faezeh Aghajannataj is poised to make lasting contributions to the fields of biotechnology and pharmaceutical sciences. Her innovative approach to drug delivery systems and her commitment to research excellence set her apart as a leading figure in her field. As she continues her career, her work is likely to inspire future research and development in the industry, particularly in the creation of more sustainable and effective pharmaceutical solutions.

🎓Publication 

Ethanol fermentation in an immobilized cell reactor using Saccharomyces cerevisiae

  • Authors   :Ghasem Najafpour, Habibollah Younesi, Ku Syahidah Ku Ismail
  • Journal    :Bioresource technology
  • Year         :2024

Piperine—the bioactive compound of black pepper: from isolation to medicinal formulations

  • Authors   :Leila Gorgani, Maedeh Mohammadi, Ghasem D Najafpour, Maryam Nikzad
  • Journal    :Comprehensive reviews in food science and food safety
  • Year         :2017

High-rate anaerobic digestion of palm oil mill effluent in an upflow anaerobic sludge-fixed film bioreactor

  • Authors   :GD Najafpour, AAL Zinatizadeh, AR Mohamed, M Hasnain Isa, H Nasrollahzadeh
  • Journal    :Process Biochemistry
  • Year         :2006

Treatment of pulp and paper mill wastewater by polyacrylamide (PAM) in polymer induced flocculation

  • Authors   :SS Wong, TT Teng, AL Ahmad, A Zuhairi, G Najafpour
  • Journal    :Journal of hazardous materials
  • Year         :2006

Power generation from organic substrate in batch and continuous flow microbial fuel cell operations

  • Authors   :Mostafa Rahimnejad, Ali Asghar Ghoreyshi, Ghasem Najafpour, Tahereh Jafary
  • Journal    :Applied Energy
  • Year         :2011

Prof.Aleksandr Urakov|Drug Repurposing | Best Researcher Award

Prof.Aleksandr Urakov, Drug Repurposing ,Best Researcher Award

Prof.Aleksandr Urakov atIzhevsk State Medical Academy,Russia

PROFILE  

scopus

Orcid

Academic Leadership 🏫

Professor Aleksandr Urakov serves as the head of the Department of General and Clinical Pharmacology at Izhevsk State Medical Academy. His leadership has been instrumental in shaping the department into a center of excellence in pharmacological research and education.

Innovative Contributions 🧠

As an inventor, Professor Urakov holds over 270 patents and has published more than 200 scientific articles . His research in temperature pharmacology and drug repurposing  has led to significant advancements, including the development of the floating tablet and warm alkaline hydrogen peroxide solutions .

Recognition and Honors 🎖️

For his remarkable contributions, Professor Urakov has been awarded the Order of the Badge of Honor and holds the prestigious title of Honored Inventor of the Russian Federation . His work continues to influence and inspire the medical community globally.

Research and Innovations🔬 :

Professor Urakov invented the floating tablet and discovered warm alkaline hydrogen peroxide solutions (WAHPSs), which include new drug subgroups like bruise bleaches, pus-dissolving drugs (pyolytics), and oxygen-producing antihypoxants. These innovations offer alternatives to ECMO for hypoxemia in COVID-19 asphyxia.

🎓Publication 

Comment: Balanced Salt Solutions for Critically Ill Patients: Nonplused and Back to Basics

Thermal imaging of local skin temperature as part of quality and safety assessment of injectable drugs

    • Authors :Urakov, A., Urakova, N., Samorodov, A., Suntsova, D., Muhutdinov, N..
    • Journal   :Heliyon
    • Year       : 2024

Understanding burn injuries in children – A step toward prevention and prompt first aid

  • Authors  :Urakov, A.L., Suntsova, D.O., Yagudin, I.I.
  • Journal    :Burns
  • Year         :  2023

ASSESSMENT OF FETAL RESISTANCE TO HYPOXIA USING THE STANGE TEST AS AN ADJUNCT TO APGAR SCALE ASSESSMENT OF NEONATAL HEALTH STATUS

  • Authors  :Shabanov, P.D., Urakov, A.L., Urakova, N.A.
  • Journal   :Medicinskij Akademiceskij Zurnal,
  • Year        :   2023

Prospects for the pharmacological validation of the use of platelets as a “peripheral model” of neurons